However, disparities exist among cancer survivors by race and health coverage
Top concerns include life expectancy, course of treatment, and pain
About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy
About half of physicians would consider euthanasia as a good or very good option in a scenario of advanced cancer or Alzheimer disease
One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent
Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors
Stronger effects seen for women from some racial/ethnic minority groups and with lower socioeconomic status
Maximal survival benefit seen for smoking cessation treatment within six months of diagnosis
Significant reduction seen in secondary outcome of long-term depression but not in medium-term depression